Proportion of individuals’ general benefits scores that increased, decreased, or remained unchanged between time points. by Jessie B. Moore (12578140)

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Myelinopathy results in a significantly reduced spike probability and increased latency after a release event. by Maral Budak (6680351)

Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

The apparent Ca²⁺ affinity of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

“…<b>B,</b> Ca²⁺ curves normalized to maximum EJP amplitude predicted by the nonlinear regression. The significant rightward shift in the curve (EC50, non overlapping confidence intervals) indicates a decrease in the apparent Ca²⁺ affinity of neurotransmitter release.…”

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). by Yunmeng Da (707943)

Increases and decreases in resources. by Guangliang Li (194029)

Decrease in cell movement as revealed by IPA. by Afrooz Jahedi (14636554)

Cephalometric measurement points. by Lijuan Liu (136685)

Dexamethasone (DEX) treatments inhibited bud outgrowth, increased the ABA level, and decreased cytokinin (tZ and iP) levels in the terminal buds of <i>35S</i>:<i>PmDAM6-GR</i> plan... by Hisayo Yamane (6569942)

Join-point regression analysis of the statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Point-mass model. by Guilong Xu (13281902)

Changepoint analysis in comparison of MarBTN-specific eDNA and cancer in hemolymph. by Rachael M. Giersch (22331947)

Subjects:

Modeling the relationship between cancer level in hemolymph and MarBTN in tank eDNA. by Rachael M. Giersch (22331947)

Subjects:

MarBTN-specific eDNA detection in each clam that was followed for MarBTN in hemolymph and eDNA. by Rachael M. Giersch (22331947)

Subjects:

Agreement between microscopy and qPCR analysis of MarBTN progression. by Rachael M. Giersch (22331947)

Subjects:

Detection of MarBTN-specific eDNA in tank water at late stages of MarBTN progression. by Rachael M. Giersch (22331947)

Subjects:

Perioperative factors associated with differences in adjusted hospitalization costs; all displayed factors are significantly associated with increased or decreased adjusted costs. by Saad Mallick (17283479)